UNH

UnitedHealth Group Incorporated (UNH) | Rumor.io

UnitedHealth Group

UNH

Attention (50-day avg)0.03%

Attention rank (50-day avg)#209

Bullish sentiment (50-day avg)87%

Price to earnings ratio24.2

Market capitalization339.1B

Earnings per share15.6

Dividend yield (TTM)2.48%

Revenue (annual)447.6B

Net income (annual)12.8B

Social

What share of all stock conversation is about UNH?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% -0.02	0.02% +0	0.03% -0.01	0.21% -0.44

Sep 29

UnitedHealth Group Incorporated is making changes to its organizational structure, with the recent appointment of Jodee Kozlak as the company's first chief administrative officer, overseeing HR, real estate, procurement, and other functions.
The company's stock has been subject to market manipulation, with traders attempting to drive the price down during regular trading sessions after a strong premarket performance.
There have been allegations of UnitedHealth denying medical care to patients who had previously been approved, with one post citing a specific instance of 1,700 patients being denied care.

Generated by AI

Sentiment

Of the messages about UNH that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	79.26% -13.87	90.47% +8.23	79.05% +4.58
Bearish	—	20.74% +13.87	9.53% -8.23	20.95% -4.58

Bullish· Sep 11

The recent stock weakness in $UNH creates an attractive valuation, making it a good opportunity to invest.
The company is poised to resume its steady path of double-digit compounding, making it a solid long-term investment.
Buying $UNH in the 350 range could be a good strategy, with the potential for the stock to reach $380 or higher.

Bearish· Sep 11

$UNH (UnitedHealth Group Incorporated) has broken down from a bear flag and may continue to decline with wave (C) down.
The stock has been manipulated, with no negative news to justify the decline, and is down 23% since strong earnings.
The stock's recent performance is unusual, with no new information to warrant the decline, and is now trading at levels that may indicate a potential bounce or short covering.

Generated by AI

Topics

Of the messages about UNH that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Controversies	0%	0%	0.56%	0.2%
Macro	0%	18.62%	19.84%	44.43%
Technical Analysis	100%	28.57%	24.59%	9.54%
Announcements	0%	32.4%	26.65%	3.33%
Analysts	0%	10.46%	13.62%	21.29%
Earnings	0%	9.95%	14.73%	21.22%

Earnings· Jul 17

UnitedHealth Group reported a huge earnings beat, with adjusted EPS of $6.38 vs. $4.90 expected, and raised full-year EPS guidance to $19.50-$20.00.
The company's Q2 earnings report showed a 56.4% YoY earnings growth, with adjusted EPS growing to $6.38, and management affirming this new earnings range as a "durable" baseline for future growth.
The stock surged over 8% after the earnings report, and has nearly doubled off its $235 low, with investors confident in the underlying fundamentals and trajectory of the company.

Analysts· Jul 17

Morgan Stanley raised the price target for UnitedHealth Group (UNH) to $529 from $468, citing improving confidence in execution and long-term earnings potential.
Analysts expect UnitedHealth's recovery story to continue, driven by improving margins, medical cost trends, and guidance, but investors are watching closely for signs of margin recovery and long-term growth.
UnitedHealth's Q2 2026 earnings crushed expectations, with adjusted EPS of $6.38, and management raised full-year adjusted EPS guidance to $19.50-$20.00, but the stock's nearly doubled off its low and is near the top of its range.

Announcements· Jul 16

UnitedHealth Group's Q2 2026 earnings report exceeded expectations, with revenue of $112.0B and adjusted EPS of $6.38, a 56% YoY increase.
The company raised its FY26 guidance, with adjusted EPS expected to be between $19.50-$20.00, a 12% lift from the previous estimate.
UnitedHealth's strong earnings beat and guidance raise were driven by its focus on efficiency, including a $1.5B AI investment, and its efforts to improve operations and reduce costs.

Controversies· Jan 27

The Trump administration's proposal for fixed Medicare prices in 2026 has led to a sharp decline in UnitedHealth Group Incorporated's stock price, with a 8% drop in post-market trading.
The proposal, which is well below market expectations, has put pressure on the company's margins, with the market expecting a 4-6% increase instead of the proposed 0.09% net average payment increase for Medicare Advantage plans in 2027.
The proposal has also raised concerns about the potential impact on healthcare companies, with UnitedHealth Group Incorporated's stock price wiping out $65 billion in market value, its worst day since April 17th.

Macro· May 7

UnitedHealth Group's stock was a top performer in April, with strong earnings driving its positive performance.
The company's earnings beat expectations, contributing to its strong showing in the global financial markets.
UnitedHealth's stock has been a subject of debate between bulls and bears, with some questioning its prospects.

Technical Analysis· Aug 20

The stock has been in a downtrend, with a failed breakout in 2H 2024, and is currently in the process of putting in a monthly evening star pattern, which has an 80% chance of leading to further downside.
The stock has rejected the 200WMA and has had nothing but red weeks for over a month, with likely support at $372.60 or touching the 50Week at $345.85.
The stock's RSI is 27.7, indicating it is oversold, and there is a high probability of profit for a naked put at strike 370.0, with an annualized return of 15.5% and a probability of profit of 75.9%.

Generated by AI

Community

Of the messages about UNH, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	18.18%	70.87%	70.37%	62.82%
Newcomers	81.82%	29.13%	29.63%	37.18%

Regulars· Sep 25

The regulars are focused on the growth of UNH, with quarterly revenue increasing from $70B in 2021 to $112B now, despite the stock price remaining the same as in April 2021.
Trump's recent filing shows heavy buying in healthcare, specifically in UNH, Abbott, Becton Dickinson, Pfizer, and AbbVie.
The regulars are monitoring UNH's price action, with some expecting a breakout above $380, while others are anticipating a manipulation of the stock price, and still others are waiting for a turn-around after the stock's recent decline.

Newcomers· Sep 11

The new users are focused on the potential impact of a company's ability to build guided ballistic missiles on health insurance premiums, and whether this could be bearish for UnitedHealth Group.
Some users are concerned about the technical analysis of UNH stock, specifically the breakdown from a bear flag and the completion of wave (B), which they believe may lead to a wave (C) down.
Others are puzzled by the stock's 35% increase in six months, and are questioning whether health insurance companies should be allowed to make such high profits, with some referencing the pre-Obamacare era when these companies traded at significantly lower prices.

Generated by AI

UnitedHealth Group Incorporated (NYSE:UNH) is getting a new head of its insurance division, with executive Robert Hunter disclosing on September 28 that he will take the role. Hunter announced it himself in a post on LinkedIn, and the firm has issued no comments on the reasoning. The division he is taking over is the one […]

4h agoYahoo Finance

Here's How Much $100 Invested In UnitedHealth Group 15 Years Ago Would Be Worth Today - UnitedHealth Grou

UnitedHealth Group (NYSE:UNH) has outperformed the market over the past 15 years by 1.78% on an annualized basis producing an average annual return of 15.28%. Currently, UnitedHealth Group has a market capitalization of

13h agoBenzinga

I sold UnitedHealth shares when the business stumbled. Here's why I'm buying again

UnitedHealth is showing signs of improvement after higher medical costs pressured earnings and margins, and Kevin Simpson is starting to buy the stock again.

18h agoCNBC

UnitedHealth, AbbVie And A Health Care Stock On CNBC’s ‘Final Trades’ - AbbVie (NYSE:ABBV)

CNBC’s final trades: Weiss picked UnitedHealth, Lebenthal chose AbbVie after FDA approval, and Terranova backed Okta amid raised price targets.

20h agobenzinga.com

UnitedHealth Stock Has Gone Nowhere for Five Years. Its Dividend Has Not

21h agoYahoo Finance

Also Discussed

Investors talking about UNH also mention

#	Name	Attention
1	Elevance Health, Inc.ELV	0%new
2	Centene CorpCNC	0%0
3	Humana Inc.HUM	0%+0
4	Oscar Health, Inc.OSCR	0.05%+0.02
5	Novo Nordisk A/S Sponsored ADRNVO	0.14%-0.04
6	The Cigna GroupCI	0%0
7	Molina Healthcare Inc.MOH	0%new
8	CVS Health CorporationCVS	0%0
9	Eli Lilly and CompanyLLY	0.16%+0.07
10	lululemon athletica inc.LULU	0.01%+0.01

UnitedHealth Group Incorporated

Healthcare
Healthcare Plans

UnitedHealth Group Incorporated is a diversified health care company that provides health benefit plans, medical services, pharmacy care, and health technology solutions. Through UnitedHealthcare, it offers coverage for individuals, employers, Medicare and Medicaid beneficiaries, supporting access to care through broad provider networks and member services. Its Optum businesses deliver care delivery, pharmacy benefit management, data analytics, consulting, and software tools that support hospitals, physicians, payers, and public-sector clients. The company serves consumers, health care professionals, employers, and government organizations across the United States and internationally, making it a major participant in managed care and health services. UnitedHealth Group Incorporated plays a central role in connecting insurance, clinical care, and data-driven operations within the health care market.

Website

Location

1 Health Drive

Eden Prairie, MN, 55344

United States

Social

What share of all stock conversation is about UNH?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% -0.02	0.02% +0	0.03% -0.01	0.21% -0.44

Sep 29

UnitedHealth Group Incorporated is making changes to its organizational structure, with the recent appointment of Jodee Kozlak as the company's first chief administrative officer, overseeing HR, real estate, procurement, and other functions.
The company's stock has been subject to market manipulation, with traders attempting to drive the price down during regular trading sessions after a strong premarket performance.
There have been allegations of UnitedHealth denying medical care to patients who had previously been approved, with one post citing a specific instance of 1,700 patients being denied care.

Generated by AI

Sentiment

Of the messages about UNH that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	79.26% -13.87	90.47% +8.23	79.05% +4.58
Bearish	—	20.74% +13.87	9.53% -8.23	20.95% -4.58

Bullish· Sep 11

The recent stock weakness in $UNH creates an attractive valuation, making it a good opportunity to invest.
The company is poised to resume its steady path of double-digit compounding, making it a solid long-term investment.
Buying $UNH in the 350 range could be a good strategy, with the potential for the stock to reach $380 or higher.

Bearish· Sep 11

$UNH (UnitedHealth Group Incorporated) has broken down from a bear flag and may continue to decline with wave (C) down.
The stock has been manipulated, with no negative news to justify the decline, and is down 23% since strong earnings.
The stock's recent performance is unusual, with no new information to warrant the decline, and is now trading at levels that may indicate a potential bounce or short covering.

Generated by AI

Topics

Of the messages about UNH that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Controversies	0%	0%	0.56%	0.2%
Macro	0%	18.62%	19.84%	44.43%
Technical Analysis	100%	28.57%	24.59%	9.54%
Announcements	0%	32.4%	26.65%	3.33%
Analysts	0%	10.46%	13.62%	21.29%
Earnings	0%	9.95%	14.73%	21.22%

Earnings· Jul 17

UnitedHealth Group reported a huge earnings beat, with adjusted EPS of $6.38 vs. $4.90 expected, and raised full-year EPS guidance to $19.50-$20.00.
The company's Q2 earnings report showed a 56.4% YoY earnings growth, with adjusted EPS growing to $6.38, and management affirming this new earnings range as a "durable" baseline for future growth.
The stock surged over 8% after the earnings report, and has nearly doubled off its $235 low, with investors confident in the underlying fundamentals and trajectory of the company.

Analysts· Jul 17

Morgan Stanley raised the price target for UnitedHealth Group (UNH) to $529 from $468, citing improving confidence in execution and long-term earnings potential.
Analysts expect UnitedHealth's recovery story to continue, driven by improving margins, medical cost trends, and guidance, but investors are watching closely for signs of margin recovery and long-term growth.
UnitedHealth's Q2 2026 earnings crushed expectations, with adjusted EPS of $6.38, and management raised full-year adjusted EPS guidance to $19.50-$20.00, but the stock's nearly doubled off its low and is near the top of its range.

Announcements· Jul 16

UnitedHealth Group's Q2 2026 earnings report exceeded expectations, with revenue of $112.0B and adjusted EPS of $6.38, a 56% YoY increase.
The company raised its FY26 guidance, with adjusted EPS expected to be between $19.50-$20.00, a 12% lift from the previous estimate.
UnitedHealth's strong earnings beat and guidance raise were driven by its focus on efficiency, including a $1.5B AI investment, and its efforts to improve operations and reduce costs.

Controversies· Jan 27

The Trump administration's proposal for fixed Medicare prices in 2026 has led to a sharp decline in UnitedHealth Group Incorporated's stock price, with a 8% drop in post-market trading.
The proposal, which is well below market expectations, has put pressure on the company's margins, with the market expecting a 4-6% increase instead of the proposed 0.09% net average payment increase for Medicare Advantage plans in 2027.
The proposal has also raised concerns about the potential impact on healthcare companies, with UnitedHealth Group Incorporated's stock price wiping out $65 billion in market value, its worst day since April 17th.

Macro· May 7

UnitedHealth Group's stock was a top performer in April, with strong earnings driving its positive performance.
The company's earnings beat expectations, contributing to its strong showing in the global financial markets.
UnitedHealth's stock has been a subject of debate between bulls and bears, with some questioning its prospects.

Technical Analysis· Aug 20

The stock has been in a downtrend, with a failed breakout in 2H 2024, and is currently in the process of putting in a monthly evening star pattern, which has an 80% chance of leading to further downside.
The stock has rejected the 200WMA and has had nothing but red weeks for over a month, with likely support at $372.60 or touching the 50Week at $345.85.
The stock's RSI is 27.7, indicating it is oversold, and there is a high probability of profit for a naked put at strike 370.0, with an annualized return of 15.5% and a probability of profit of 75.9%.

Generated by AI

Community

Of the messages about UNH, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	18.18%	70.87%	70.37%	62.82%
Newcomers	81.82%	29.13%	29.63%	37.18%

Regulars· Sep 25

The regulars are focused on the growth of UNH, with quarterly revenue increasing from $70B in 2021 to $112B now, despite the stock price remaining the same as in April 2021.
Trump's recent filing shows heavy buying in healthcare, specifically in UNH, Abbott, Becton Dickinson, Pfizer, and AbbVie.
The regulars are monitoring UNH's price action, with some expecting a breakout above $380, while others are anticipating a manipulation of the stock price, and still others are waiting for a turn-around after the stock's recent decline.

Newcomers· Sep 11

The new users are focused on the potential impact of a company's ability to build guided ballistic missiles on health insurance premiums, and whether this could be bearish for UnitedHealth Group.
Some users are concerned about the technical analysis of UNH stock, specifically the breakdown from a bear flag and the completion of wave (B), which they believe may lead to a wave (C) down.
Others are puzzled by the stock's 35% increase in six months, and are questioning whether health insurance companies should be allowed to make such high profits, with some referencing the pre-Obamacare era when these companies traded at significantly lower prices.

Generated by AI

UnitedHealth Group

Social

Sep 29

Bullish· Sep 11

Bearish· Sep 11

Earnings· Jul 17

Analysts· Jul 17

Announcements· Jul 16

Controversies· Jan 27

Macro· May 7

Technical Analysis· Aug 20

Regulars· Sep 25

Newcomers· Sep 11

UnitedHealth: The Recovery Is Working, The Stock Isn't (NYSE:UNH)

Robert Hunter Named UnitedHealth (UNH) Insurance President

Here's How Much $100 Invested In UnitedHealth Group 15 Years Ago Would Be Worth Today - UnitedHealth Grou

I sold UnitedHealth shares when the business stumbled. Here's why I'm buying again

UnitedHealth, AbbVie And A Health Care Stock On CNBC’s ‘Final Trades’ - AbbVie (NYSE:ABBV)

UnitedHealth Stock Has Gone Nowhere for Five Years. Its Dividend Has Not

Also Discussed

UnitedHealth Group Incorporated

Company Information

Location

UnitedHealth: The Recovery Is Working, The Stock Isn't (NYSE:UNH)

Robert Hunter Named UnitedHealth (UNH) Insurance President

Here's How Much $100 Invested In UnitedHealth Group 15 Years Ago Would Be Worth Today - UnitedHealth Grou

I sold UnitedHealth shares when the business stumbled. Here's why I'm buying again

UnitedHealth, AbbVie And A Health Care Stock On CNBC’s ‘Final Trades’ - AbbVie (NYSE:ABBV)

UnitedHealth Stock Has Gone Nowhere for Five Years. Its Dividend Has Not

Also Discussed

Social

Sep 29

Bullish· Sep 11

Bearish· Sep 11

Earnings· Jul 17

Analysts· Jul 17

Announcements· Jul 16

Controversies· Jan 27

Macro· May 7

Technical Analysis· Aug 20

Regulars· Sep 25

Newcomers· Sep 11